SPOP and neoplasm: Besides, SPOP missense mutations are reported to contribute to higher PD-L1 expression by preventing its ubiquitination-mediated degradation, thus producing a more immunosuppressive tumor microenvironment (TME) and facilitating tumors more likely responsive to anti-PD-L1 (59).